Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Drugs Under Experimental and Clinical Research|January 1, 1987
Azthreonam in the treatment of urinary tract infection: evaluation of efficacy, renal effects and nephrotoxicityC Donadio, G Tramonti, G Garcea, et al.
Investigational New Drugs|September 18, 1998
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinomaM M Zalupski, A F Shields, P A Philip, et al.
Nephrologie|January 1, 1992
[Renal accumulation of radioiodinated alpha-1-microglobulin increases in the mononephrectomised rat]C Bianchi, C Donadio, G Tramonti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934)P LoRusso, B J Foster, E Poplin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2018
A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumorsR Ferrarotto, G Eckhardt, A Patnaik, et al.
Investigational New Drugs|March 10, 2015
Safety, tolerability, and pharmacokinetics of single and multiple doses of intravenous cixutumumab (IMC-A12), an inhibitor of the insulin-like growth factor-I receptor, administered weekly or every 2 weeks in patients with advanced solid tumorsC S Higano, J Berlin, M Gordon, et al.
British Journal of Cancer|February 16, 2013
Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinomaA Naing, P Lorusso, S Fu, et al.
Cancer Research|August 15, 1990
Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of miceP LoRusso, A J Wozniak, L Polin, et al.
Investigational New Drugs|November 22, 2013
A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumorsD S Hong, R Kurzrock, A Naing, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancerE A Poplin, P LoRusso, J J Lokich, et al.
Pageof 5